Mesalamine Suppositories are indicated in adults for the treatment of mildly to moderately active ulcerative proctitis.
According to the company, the US Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for
Mesalamine Delayed-Release Tablets USP in 1.2 g for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC) and for the maintenance of remission of UC.
But the length of colorectum in
mesalamine and Portulaca group was longer than that in DSS group (Figure 1(e)).
Mesalamine is an aminosalicylate anti-inflammatory drug commonly prescribed in patients with IBD.
Curcumin in combination with
mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial.
There was no response to
mesalamine given initially but intestinal symptoms and ulcerative skin lesion improved with prednisolone which was administered later.
She was started on
mesalamine, 4 mg/day, but 1 month later, she developed a Crohn flare and was started on ciprofloxacin, 500 mg/day, and 6-MP, 50 mg/day, with good response.
In 2007, PharmaZell built a commercial production plant in Vizag, India to produce the active pharmaceutical ingredient,
Mesalamine. In 2008, PharmaZell continued expanding in Vizag by building a state of the art R&D facility.
Among the leading Rx brands that Warner Chilcott receives are Asacol HD (
mesalamine) delayed-release tablets for ulcerative colitis, Actonel (risedronate sodium) for osteoporosis and copromotion rights to Enablex (darifenacin) for treatment of overactive bladder.
There isn't enough evidence to recommend the anti-inflammatory drug
mesalamine or a polybacterial lysate for immunostimulation.